Jeffrey Lazarus
Dr. Jeffrey Lazarus is a public health expert at the City University of New York (CUNY) School of Public Health and Health Policy, who has been vocal about the need for effective treatments for metabolic liver diseases. He recently highlighted the breakthrough potential of semaglutide for patients with fatty liver disease and fibrotic conditions.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 1 | 8.00 | 0.04% | +0% | 67,886,011 | 28,692 | $2,700,000 | 1,141$ |
| Totals | 1 | 67,886,011 | 28,692 | $2,700,000 | 1,141$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Dr Jeffrey Lazarus is the lead author of the paper and a professor of global health in New York and Barcelona.
8
Israel:
Dr. Jeffrey Lazarus from the City University of New York School of Public Health and Health Policy describes the findings as groundbreaking news.
9